Natural Compounds Targeting Coronary Microvascular Dysfunction: Mechanisms and Beyond
Drug Design, Development and Therapy · 2026-03 · Volume 20 · 1-19
DOI: 10.2147/dddt.s591542 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-03. Verfasst von Mingtai Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, 518000, People's Republic of China. Hauptthemen laut MEDLINE: Biological Products, Coronary Vessels, Microvessels, Coronary Artery Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Coronary microvascular dysfunction (CMD) is increasingly recognized as a major public health burden, independently contributing to myocardial ischemia, adverse cardiovascular events, and elevated healthcare costs. Its pathophysiology is multifactorial, involving endothelial dysfunction, microthrombosis, and metabolic disturbances. Natural compounds, owing to their multi-target effects and favorable safety profiles, have emerged as promising candidates for CMD intervention. This narrative review systematically consolidates current evidence on the key molecular targets and regulatory mechanisms through which natural compounds preserve microvascular homeostasis. It also highlights shared pathological pathways between CMD and other cardiovascular diseases to support cross-disease therapeutic translation. By integrating these findings, this review aims to establish a theoretical foundation for future preclinical and clinical applications of natural compounds in CMD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, 518000, People's Republic of China.
- Chinese Medicine Guangdong Laboratory (Hengqin Laboratory), Guangdong-Macao In-Depth Cooperation Zone in Hengqin, Zhuhai, 519000, People's Republic of China.
- Faculty of Chinese Medicine and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao, 999078, People's Republic of China.
- The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, People's Republic of China.
- Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, 646000, People's Republic of China.
- School of Pharmacy, Southwest Medical University, Luzhou, 646000, People's Republic of China.
ORCID-Profile: Xinrui Yang, Mengnan Liu
Zitieren
APA
Chen, M., Xiang, X., Yang, X., Fu, Y., Wan, Z., Yang, S., Liu, Q., Luo, G., & Liu, M. (2026). Natural Compounds Targeting Coronary Microvascular Dysfunction: Mechanisms and Beyond. Drug Design, Development and Therapy, Volume 20, 1-19. https://doi.org/10.2147/dddt.s591542
Vancouver
Chen M, Xiang X, Yang X, Fu Y, Wan Z, Yang S, et al. Natural Compounds Targeting Coronary Microvascular Dysfunction: Mechanisms and Beyond. Drug Design, Development and Therapy. 2026;Volume 20:1-19. doi:10.2147/dddt.s591542
BibTeX
@article{Chen2026,
author = {Chen, Mingtai and Xiang, Xinyi and Yang, Xinrui and Fu, Youyou and Wan, Zhenxun and Yang, Shiyun and Liu, Qiuyu and Luo, Gang and Liu, Mengnan},
title = {Natural Compounds Targeting Coronary Microvascular Dysfunction: Mechanisms and Beyond},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--19},
doi = {10.2147/dddt.s591542}
}
EUVIMED